-
1
-
-
33846974021
-
Cost of cancer care: Issues and implications
-
Meropol NJ, Schulman KA. Cost of cancer care: issues and implications. J Clin Oncol. 2007;25(2):180-186.
-
(2007)
J Clin Oncol.
, vol.25
, Issue.2
, pp. 180-186
-
-
Meropol, N.J.1
Schulman, K.A.2
-
2
-
-
84878079921
-
If slow rate of health care spending growth persists, projections may be off by $770 billion
-
Cutler DM, Sahni NR. If slow rate of health care spending growth persists, projections may be off by $770 billion. Health Aff (Millwood). ;32(5):841-850.
-
Health Aff (Millwood).
, vol.32
, Issue.5
, pp. 841-850
-
-
Cutler, D.M.1
Sahni, N.R.2
-
3
-
-
84877967115
-
The slowdown in health care spending in 2009-11 reflected factors other than the weak economy and thus may persist
-
Ryu AJ, Gibson TB, McKellar MR, Chernew ME. The slowdown in health care spending in 2009-11 reflected factors other than the weak economy and thus may persist. Health Aff (Millwood). 2013;32(5):835-840.
-
(2013)
Health Aff (Millwood).
, vol.32
, Issue.5
, pp. 835-840
-
-
Ryu, A.J.1
Gibson, T.B.2
McKellar, M.R.3
Chernew, M.E.4
-
4
-
-
79960217089
-
National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008
-
Bernard DS, Farr SL, Fang Z. National estimates of out-of-pocket health care expenditure burdens among nonelderly adults with cancer: 2001 to 2008. J Clin Oncol. 2011;29(20):2821-2826.
-
(2011)
J Clin Oncol.
, vol.29
, Issue.20
, pp. 2821-2826
-
-
Bernard, D.S.1
Farr, S.L.2
Fang, Z.3
-
5
-
-
84883244153
-
Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting
-
Wong YN, Egleston BL, Sachdeva K, et al. Cancer patients' trade-offs among efficacy, toxicity, and out-of-pocket cost in the curative and noncurative setting. Med Care. 2013;51(9):838-845.
-
(2013)
Med Care.
, vol.51
, Issue.9
, pp. 838-845
-
-
Wong, Y.N.1
Egleston, B.L.2
Sachdeva, K.3
-
6
-
-
77954963593
-
Understanding how out-ofpocket expenses, treatment value, and patient characteristics influence treatment choices
-
Wong YN, Hamilton O, Egleston B, et al. Understanding how out-ofpocket expenses, treatment value, and patient characteristics influence treatment choices. Oncologist. 2010;15(6):566-576.
-
(2010)
Oncologist.
, vol.15
, Issue.6
, pp. 566-576
-
-
Wong, Y.N.1
Hamilton, O.2
Egleston, B.3
-
7
-
-
79959325702
-
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer
-
Neugut AI, Subar M, Wilde ET, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18):2534-2542.
-
(2011)
J Clin Oncol.
, vol.29
, Issue.18
, pp. 2534-2542
-
-
Neugut, A.I.1
Subar, M.2
Wilde, E.T.3
-
8
-
-
84863761318
-
Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis
-
Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: A population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608-1614.
-
(2012)
J Clin Oncol.
, vol.30
, Issue.14
, pp. 1608-1614
-
-
Shankaran, V.1
Jolly, S.2
Blough, D.3
Ramsey, S.D.4
-
9
-
-
84874631714
-
The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience
-
Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: A pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. Oncologist. 2013;18(4):381-390.
-
(2013)
Oncologist.
, vol.18
, Issue.4
, pp. 381-390
-
-
Zafar, S.Y.1
Peppercorn, J.M.2
Schrag, D.3
-
10
-
-
33845485717
-
Changes in financial burdens for health care: National estimates for the population younger than 65 years, 1996 to 2003
-
Banthin JS, Bernard DM. Changes in financial burdens for health care: national estimates for the population younger than 65 years, 1996 to 2003. JAMA. 2006;296(22):2712-2719.
-
(2006)
JAMA
, vol.296
, Issue.22
, pp. 2712-2719
-
-
Banthin, J.S.1
Bernard, D.M.2
-
11
-
-
84879256683
-
Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis
-
Ramsey S, Blough D, Kirchhoff A, et al. Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff (Millwood). 2013;32(6):1143-1152.
-
(2013)
Health Aff (Millwood).
, vol.32
, Issue.6
, pp. 1143-1152
-
-
Ramsey, S.1
Blough, D.2
Kirchhoff, A.3
-
12
-
-
84890510428
-
Addressing the american health-care cost crisis: Role of the oncology community
-
Ramsey SD, Ganz PA, Shankaran V, Peppercorn J, Emanuel E. Addressing the American health-care cost crisis: role of the oncology community. J Natl Cancer Inst. 2013;105(23):1777-1781.
-
(2013)
J Natl Cancer Inst.
, vol.105
, Issue.23
, pp. 1777-1781
-
-
Ramsey, S.D.1
Ganz, P.A.2
Shankaran, V.3
Peppercorn, J.4
Emanuel, E.5
-
13
-
-
84890490214
-
-
Education Program Presentation At The Annual Meeting Of The American Society Of Clinical Oncology; June 1 2013; Chicago IL. Accessed October 9
-
Meropol NJ, Ellis LM, Visco F. Raising the bar: setting standards for real progress in clinical trials. Education Program presentation at the Annual Meeting of the American Society of Clinical Oncology; June 1, 2013; Chicago, IL. http://meetinglibrary.asco.org/presentationBySession/5868/1295. Accessed October 9, 2013.
-
(2013)
Raising The Bar: Setting Standards For Real Progress In Clinical Trials
-
-
Meropol, N.J.1
Ellis, L.M.2
Visco, F.3
-
14
-
-
84855838189
-
Value-based insurance design: Aligning incentives, benefits, and evidence in oncology
-
de Souza JA, Ratain MJ, Fendrick AM. Value-based insurance design: Aligning incentives, benefits, and evidence in oncology. J Natl Compr Canc Netw. 2012;10(1):18-23.
-
(2012)
J Natl Compr Canc Netw.
, vol.10
, Issue.1
, pp. 18-23
-
-
De Souza, J.A.1
Ratain, M.J.2
Fendrick, A.M.3
-
15
-
-
84880275207
-
Reforming the payment system for medical oncology
-
Bach PB. Reforming the payment system for medical oncology. JAMA. 2013;310(3):261-262.
-
(2013)
JAMA
, vol.310
, Issue.3
, pp. 261-262
-
-
Bach, P.B.1
-
16
-
-
84890518877
-
The nci-Asco cancer trial accrual symposium: Summary and recommendations [published online ahead of print october 29, 2013]
-
Denicoff AM, McCaskill-Stevens W, Grubbs SS, et al. The NCI-ASCO Cancer Trial Accrual Symposium: summary and recommendations [published online ahead of print October 29, 2013]. J Oncol Pract.
-
J Oncol Pract
-
-
Denicoff, A.M.1
McCaskill-Stevens, W.2
Grubbs, S.S.3
-
17
-
-
84870702055
-
Cost, coverage, and comparative effectiveness research: The critical issues for oncology
-
Pearson SD. Cost, coverage, and comparative effectiveness research: the critical issues for oncology. J Clin Oncol. 2012;30(34):4275-4281.
-
(2012)
J Clin Oncol.
, vol.30
, Issue.34
, pp. 4275-4281
-
-
Pearson, S.D.1
-
18
-
-
84870684450
-
Comparative effectiveness research to inform medical decisions: The need for common language
-
Meropol NJ. Comparative effectiveness research to inform medical decisions: the need for common language. J Clin Oncol. 2012;30(34):4192-4193.
-
(2012)
J Clin Oncol.
, vol.30
, Issue.34
, pp. 4192-4193
-
-
Meropol, N.J.1
|